Zinforo Den europeiske union - norsk - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler for systemisk bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Actos 30 mg Norge - norsk - Statens legemiddelverk

actos 30 mg

orifarm as - pioglitazonhydroklorid - tablett - 30 mg

Lipitor 10 mg Norge - norsk - Statens legemiddelverk

lipitor 10 mg

orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg

Lipitor 40 mg Norge - norsk - Statens legemiddelverk

lipitor 40 mg

orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg

Lipitor 80 mg Norge - norsk - Statens legemiddelverk

lipitor 80 mg

orifarm as - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg

Somac 20 mg Norge - norsk - Statens legemiddelverk

somac 20 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Somac 20 mg Norge - norsk - Statens legemiddelverk

somac 20 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg

Somac 40 mg Norge - norsk - Statens legemiddelverk

somac 40 mg

orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg

Trileptal 300 mg Norge - norsk - Statens legemiddelverk

trileptal 300 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg

Trileptal 300 mg Norge - norsk - Statens legemiddelverk

trileptal 300 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg